108 employees
PetDx is a molecular diagnostics company dedicated to the detection and treatment of cancer in pets.
2019
$62M
from 7 investors over 7 rounds
PetDx raised $62M on December 9, 2021
Investors: K4 Group, Declaration Partners LP, Torch Capital, Aperture Venture Partners, Valor Equity Partners and Labcorp
PetDx raised $10M on June 1, 2020
Investors: -